Nov 14, 2024 Posted on 14 November 202414 November 2024 AstraZeneca and Merck’s Koselugo delivers phase 3 trial win in adults with NF1, teeing up filings
Nov 07, 2024 Posted on 7 November 20247 November 2024 After Lilly’s GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy
Nov 05, 2024 Posted on 5 November 20245 November 2024 Allurion boasts over 17% weight loss with swallowable balloon device
Nov 04, 2024 Posted on 4 November 20246 November 2024 BioNTech reports surprising COVID vaccine sales in Q3 but tempers expectations for annual sales
Oct 21, 2024 Posted on 21 October 20246 November 2024 Sanofi in ‘exclusive negotiations’ to sell 50% stake in €16B consumer health unit Opella
Oct 17, 2024 Posted on 17 October 202417 October 2024 Bayer applies for EU approval of menopause drug elinzanetant
Oct 07, 2024 Posted on 7 October 20247 October 2024 Oncolytics targets accelerated approval for oncolytic virus therapy
Oct 04, 2024 Posted on 4 October 20244 October 2024 US’ top IV fluid maker Baxter voices uncertainty about recovery timeline at North Carolina facility hit by Helene
Oct 01, 2024 Posted on 1 October 20244 October 2024 Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo
Sep 17, 2024 Posted on 17 September 20245 November 2024 Disc teases potential NDA for rare skin disorder drug
